| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 490.02 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Gestational diabetes mellitus (GDM) is a rising global health problem that affects approximately 6% of
pregnant women. Lifestyle interventions, particularly diet, and exercise are the first-line treatment, followed
by pharmacotherapy, but with associated side effects to both mother and offspring. Modulation of gut
microbiota may help prevent or manage GDM. Some gut bacterial groups associated with GDM are also
associated with inflammatory biomarkers and gut dysbiosis. Available literature reports that low-glycaemic
index diet reduces maternal fasting and 2-hour postprandial glucose and maintains a beneficial gut bacterial
composition. Pre- and probiotics can aid GDM therapy by modulating gut microbiota to eubiotic status and
improving glucose metabolism. Probiotics as adjuvant GDM therapy should consider bacterial strains,
dosage, and treatment duration. Limitations in their use require further studies to develop specific probioticbased GDM supplement therapy that impacts glycaemic control and inflammatory status by reducing
fasting plasma glucose, insulin resistance, and improving lipid profiles of pregnant women.
Description
Keywords
Gut microbiota Pregnancy Probiotics Diet Gestational diabetes mellitus
Pedagogical Context
Citation
Cruz, M., Azinheiro, S., & Pereira, S. (2023). Modulation of gut microbiota by diet and probiotics: Potential approaches to prevent gestational diabetes mellitus. Gut Microbiome, 1-36. doi:10.1017/gmb.2023.6
Publisher
Cambridge University Press
